Determining the role of Xpert® MTB/RIF in diagnosing tuberculosis in postmortem tissues
Alberto Garcia-Basteiro (Maputo, Mozambique), Alberto García-Basteiro, Mamudo Ismail, Carla Carrilho, Esperança Ussene, Paola Castillo, Dercio Chitsungo, Lucilia Lovene, Cesaltina Lorenzoni, Cristina Rodríguez, Jordi Vila, Jaume Ordi, Clara Mendendez, Quique Bassat, Miguel Martínez
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Session: WHO guidelines in TB and clinical practice
Session type: Poster Discussion
Number: 1532
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Alberto Garcia-Basteiro (Maputo, Mozambique), Alberto García-Basteiro, Mamudo Ismail, Carla Carrilho, Esperança Ussene, Paola Castillo, Dercio Chitsungo, Lucilia Lovene, Cesaltina Lorenzoni, Cristina Rodríguez, Jordi Vila, Jaume Ordi, Clara Mendendez, Quique Bassat, Miguel Martínez. Determining the role of Xpert® MTB/RIF in diagnosing tuberculosis in postmortem tissues. Eur Respir J 2015; 46: Suppl. 59, 1532
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Xpert MTB/RIF testing of pooled induced sputum Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014
Estimation of the role of the test GeneXpert MTB-RIF in the diagnosis of pulmonary tuberculosis Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014
Role of GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampacin(R) resistance in patients in high risk DRTB Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014
Clinical utility of the Xpert MTB/RIF test in induced sputum Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015
A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying mycobacterium tuberculosis during routine clinical practice Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014
Influence of early diagnostics with Xpert MTB/RIF on MDR TB patients treatment efficacy Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015
Comparative study of gene Xpert MTB/RIF, smear microscopy and TB MGIT culture in diagnosis of tuberculosis in India Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015
Tuberculosis diagnosis in rural Namibia using gene Xpert MTB/RIF testing Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR Year: 2016
Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis Source: Eur Respir J 2012; 40: 442-447 Year: 2012
Early tuberculosis treatment monitoring by Xpert® MTB/RIF Source: Eur Respir J 2012; 39: 1269-1271 Year: 2012
Detection of TB by smear microscopy and GeneXpert MTB/RIF assay in non expectorating pulmonary TB suspects and pleural TB in high prevalent low income setting Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2 Year: 2014
Utility of Xpert® MTB/RIF assay for extrapulmonary tuberculosis, a two year study Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019
Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis Source: Eur Respir J 2013; 42: 708-720 Year: 2013
Factors that predict for positive GeneXpert MTB/RIF on bronchoalveolar lavage samples in children with suspected tuberculosis Source: International Congress 2014 – Paediatric bronchology Year: 2014
Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting? Source: Eur Respir J 2012; 40: 161-168 Year: 2012
Performance of Xpert MTB/RIF Ultra for tuberculosis diagnosis in the context of passive and active case finding Source: Eur Respir J, 58 (6) 2100257; 10.1183/13993003.00257-2021 Year: 2021
Evaluation of Xpert MTB/RIF assay performance in diagnosing extrapulmonary tuberculosis among adults in a tertiary care centre in India Source: Eur Respir J 2014; 44: 1090-1093 Year: 2014
Diagnostic yield of AFB smear, culture, LiPA, GeneXpert: A clinician’s perspective Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015
Effect of history of tuberculosis on specificity of Xpert MTB/RIF Source: Eur Respir J, 56 (3) 2000343; 10.1183/13993003.00343-2020 Year: 2020
Incremental Yield of Xpert MTB/RIF Ultra over Xpert MTB/RIF in the diagnosis of extra-pulmonary tuberculosis Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis Year: 2020